FR1333711A - Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes - Google Patents

Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes

Info

Publication number
FR1333711A
FR1333711A FR809052A FR809052A FR1333711A FR 1333711 A FR1333711 A FR 1333711A FR 809052 A FR809052 A FR 809052A FR 809052 A FR809052 A FR 809052A FR 1333711 A FR1333711 A FR 1333711A
Authority
FR
France
Prior art keywords
delta4
steroids
oxo
methyl
manufacturing process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR809052A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BDH Chemicals Ltd
Original Assignee
BDH Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BDH Chemicals Ltd filed Critical BDH Chemicals Ltd
Priority to FR837319A priority Critical patent/FR970M/fr
Application granted granted Critical
Publication of FR1333711A publication Critical patent/FR1333711A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR809052A 1958-11-04 1959-11-02 Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes Expired FR1333711A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837319A FR970M (fr) 1958-11-04 1960-08-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35428/58A GB870286A (en) 1958-11-04 1958-11-04 Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds

Publications (1)

Publication Number Publication Date
FR1333711A true FR1333711A (fr) 1963-08-02

Family

ID=10377599

Family Applications (2)

Application Number Title Priority Date Filing Date
FR809052A Expired FR1333711A (fr) 1958-11-04 1959-11-02 Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes
FR837319A Active FR970M (fr) 1958-11-04 1960-08-31

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR837319A Active FR970M (fr) 1958-11-04 1960-08-31

Country Status (7)

Country Link
US (1) US3356573A (fr)
BE (1) BE584312A (fr)
CH (1) CH379493A (fr)
DE (1) DE1120446B (fr)
FR (2) FR1333711A (fr)
GB (1) GB870286A (fr)
MY (1) MY6400075A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210819B (de) * 1962-03-23 1966-02-17 Ayerst Mckenna & Harrison Verfahren zur Herstellung von in 17alpha-Stellung alkylierten Pregnanderivaten
DE1201342B (de) * 1963-03-05 1965-09-23 Olin Mathieson Verfahren zur Herstellung von Steroiden
US4370321A (en) * 1976-09-01 1983-01-25 Mead Johnson And Company Progestational adjuvant therapy
US4346037A (en) * 1981-07-10 1982-08-24 The Upjohn Company Base catalyzed acylation with enol esters
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
HUP0101809A3 (en) 1998-03-11 2002-07-29 Endorech Inc Sainte Foy Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use
US6268356B1 (en) 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6656505B2 (en) 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
US20030198679A1 (en) * 2000-11-08 2003-10-23 Kundu Subhas C. Flocculated pharmaceutical suspensions and methods for actives
CN106109435B (zh) * 2016-07-09 2018-11-06 南京臣功制药股份有限公司 一种醋酸甲地孕酮胶囊及其制备方法
CN106137993B (zh) * 2016-08-09 2018-11-09 南京臣功制药股份有限公司 一种醋酸甲地孕酮分散片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2311102A (en) * 1940-02-20 1943-02-16 Ciba Pharm Prod Inc Doubly unsaturated ketones and process of making same
CH236309A (de) * 1940-02-20 1945-01-31 Chem Ind Basel Verfahren zur Darstellung eines ,ss; , -zweifach ungesättigten Ketons.
US2900382A (en) * 1952-06-28 1959-08-18 Syntex Sa Method of making delta4,6 steroid compounds from delta4 steroid compounds
US2882282A (en) * 1957-07-17 1959-04-14 Pfizer & Co C Method of producing 3-keto-delta4, 6-steroid compounds from 3-keto a-ring saturated 6-dihydro steroid compounds
US2891079A (en) * 1959-01-23 1959-06-16 Searle & Co 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof

Also Published As

Publication number Publication date
MY6400075A (en) 1964-12-31
BE584312A (fr) 1960-05-04
CH379493A (de) 1964-07-15
DE1120446B (de) 1961-12-28
FR970M (fr) 1961-12-04
US3356573A (en) 1967-12-05
GB870286A (en) 1961-06-14

Similar Documents

Publication Publication Date Title
CH415056A (fr) Procédé de fabrication de copolymères
FR1233186A (fr) Procédé de fabrication de semi-conducteurs
FR1333711A (fr) Procédé de fabrication des 6-méthyl-3-oxo-delta4,6-stéroïdes
FR1223031A (fr) Procédé de fabrication de substances tensio-actives
BE575837A (fr) Procédé de fabrication de monocristaux semi-conducteurs.
BE614482Q (fr) Procédé de fabrication de filières
CH360966A (fr) Procédé de fabrication de vêtements plissés
FR75631E (fr) Procédé de fabrication de l'alpha-tocophéryl-quinone
BE583990A (fr) Procédé de fabrication de borures
BE591987A (fr) Procédé de fabrication de cyclopropanes.
FR1211556A (fr) Procédé de fabrication de chlorophénylchlorosilanes
OA03423A (fr) Procédé de fabrication de lingots cannelés.
FR79504E (fr) Procédé de fabrication de borazoles
BE578925A (fr) Procédé de fabrication de tôles en ferrosilicium.
FR1207512A (fr) Procédé de fabrication de catalyseur
FR1174287A (fr) Procédé de fabrication des méthyldihalogénosilanes
FR1236162A (fr) Procédé de fabrication des 3beta-hydroxy- et 3beta-acyloxy-6,16-diméthylprégna-5,16-dièn-20-one
BE576703A (fr) Procédé de fabrication de l'aniline.
FR1326317A (fr) Procédé de fabrication de 1-déshydro-6alpha,21-difluoro-21-désoxyhydrocortisone et-désoxycortisone
BE599776A (fr) Procédé de fabrication de dialkylhydrazines asymétriques
FR1264434A (fr) Procédé de fabrication des semi-celluloses
FR1242530A (fr) Procédé de fabrication de polyéthylène
FR1203486A (fr) Procédé de fabrication de nouveaux dessins de broderie
FR1266474A (fr) Procédé de fabrication de l-érythro-5-amino-6-phényl-dioxanes-1, 3.
BE574045A (fr) Procédé de fabrication industrielle de la Citrinine.